Metastatic Gastric Adenocarcinoma Active Not Recruiting Phase 1 / 2 Trials for Trastuzumab (DB00072)

Also known as: Adenocarcinoma gastric / Adenocarcinoma of stomach (disorder)

IndicationStatusPhase
DBCOND0074521 (Metastatic Gastric Adenocarcinoma)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05555251BI-1607 in Combination With Trastuzumab in Subjects With HER2-positive Advanced Solid TumorsTreatment